News

BI: Linagliptin significantly lowers blood glucose levels

BY Alaric DeArment

ORLANDO, Fla. An investigational treatment for Type 2 diabetes by Boehringer Ingelheim Pharmaceuticals significantly lowered blood sugar, according to results of a late-stage clinical study presented at a scientific meeting.

The drug maker announced Saturday the presentation of data from a phase 3 study of the once-daily pill linagliptin, saying that the drug achieved statistically significant and sustained reductions in blood sugar, according to standard measures. The results were presented at the 70th annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.

“It is imperative that blood sugar levels in people with Type 2 diabetes are adequately controlled,” Boehringer Ingelheim Pharmaceuticals executive director and medical leader for medical affairs in cardiovascular and metabolic medicine Giora Davidai said in a statement. “Uncontrolled blood sugar puts Type 2 diabetes patients at a higher risk of developing serious complications like renal impairment and cardiovascular disease, which are very common in patients with Type 2 diabetes.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

FDA approves OraSure Technologies’ hepatitis C test

BY Alaric DeArment

SILVER SPRING, Md. The Food and Drug Administration has approved a new rapid blood test for detecting hepatitis C, the agency said Friday.

The FDA approved Bethlehem, Pa.-based OraSure Technologies’ OraQuick HCV rapid antibody test, a test strip that delivers results in about 20 minutes. The test however, is not approved for HCV screening of the general population.

About 3.2 million people in the United States are chronically infected with HCV, and 17,000 people are newly infected each year. The disease can lead to liver disease and cancer, and is associated with around 12,000 deaths in the United States annually.

“Approval of OraQuick means that more patients can be notified of their HCV infection faster so that they can consult with their physicians for appropriate health measures,” FDA Center for Devices and Radiological Health director Jeffrey Shuren stated. “Getting faster treatment is an important public health step to control this dangerous disease.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

A&P expands Live Better!

BY Allison Cerra

MONTVALE, N.J. The A&P family of supermarkets has expanded the Live Better! Wellness Club for its A&P, SuperFresh, Waldbaum’s and Pathmark stores throughout the Northeast to include a new incentives program.

Fresh & Healthy Rewards provides Live Better! members with 20%-off coupons when they spend $50 in the produce section. Customers can sign up for the Live Better! wellness club at the courtesy desk or pharmacy department of their local A&P, SuperFresh, Waldbaum’s and Pathmark supermarkets.

The supermarket chain said the new program reflects its committment to providing shoppers with budget-friendly ways to maintain a healthy lifestyle.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?